Engineering and Development

Marketing

Management and Executive

Sales

Chief Financial Officer

Senior Director of Technology, Gene Therapy

Repligen Insider Sold Shares Worth $3,508,389, According to a Recent SEC Filing

Repligen–Wells Fargo: investor conference, 202509 supply service Repligen to present at Wells Fargo Healthcare Conference 2025

Repligen–Deutsche Bank: investor conference, 202509 supply service Repligen to present at Deutsche Bank Healthcare Summit 2025

Global Single-Use Bioreactors Market Set to Skyrocket to $19.9 Billion by 2032

Account Manager

Repligen Corporation is a bioprocessing-focused life sciences company that has been driving innovation in the production of biologic drugs since 1981. They are seeking a highly motivated and experienced Account Manager to sell their portfolio of upstream and downstream processing solutions to customers in the Mid-Atlantic Region, primarily focusing on Maryland and Pennsylvania.

Sign up with Google

Sign in with Google